Michito Hamada
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Molecular Biology top 10%
- Metabolism, Diabetes, and Cancer
- Epigenetics and DNA Methylation
Papers in
-
- Renal Diseases and Glomerulopathies 3
- Immunology 15
- Immune cells in cancer 9
- Co-authors
- Satoru TakahashiTakashi KudoTakashi MoriguchiJames Douglas EngelNaoki MoritoKazuteru HasegawaMasayuki YamamotoHisashi Oishi
- Journals
- Scientific Reports (6 papers)Biochemical and Biophysical Research Communications (5 papers)EXPERIMENTAL ANIMALS (3 papers)Cell Reports (3 papers)Blood (3 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Michito Hamada
52 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 104
- Immunology 426
- Molecular Biology 1.1k
- Genetics 418
- Nephrology 99
- Aging 23
Countries citing papers authored by Michito Hamada
This map shows the geographic impact of Michito Hamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michito Hamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michito Hamada more than expected).
Fields of papers citing papers by Michito Hamada
This network shows the impact of papers produced by Michito Hamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michito Hamada. The network helps show where Michito Hamada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michito Hamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2021 | 2 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 17 | |
| 7 | 2020 | 129 | |
| 8 | 2019 | 14 | |
| 9 | 2018 | 5 | |
| 10 | 2017 | 66 | |
| 11 | 2016 | 26 | |
| 12 | 2016 | 5 | |
| 13 | 2015 | 15 | |
| 14 | 2015 | 38 | |
| 15 | 2011 | 41 | |
| 16 | 2011 | 4 | |
| 17 | 2009 | 39 | |
| 18 | 2006 | 78 | |
| 19 | 2005 | 379 | |
| 20 | 2003 | 19 |
About Michito Hamada
Michito Hamada is a scholar working on Nephrology, Immunology, Cell Biology, Urology and Rehabilitation, having authored 54 papers that have together received 2.0k indexed citations. Recurring topics across this work include Immune cells in cancer (9 papers), Congenital heart defects research (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers), Epigenetics and DNA Methylation (4 papers), Spaceflight effects on biology (3 papers), Renal Diseases and Glomerulopathies (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Immunology (426 citations), Molecular Biology (1.1k citations), Genetics (418 citations), Nephrology (99 citations) and Aging (23 citations). Michito Hamada has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Satoru Takahashi, Takashi Kudo, Takashi Moriguchi, James Douglas Engel, Naoki Morito, Kazuteru Hasegawa, Masayuki Yamamoto, Hisashi Oishi, Homare Shimohata and Keigyou Yoh. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications, EXPERIMENTAL ANIMALS, Cell Reports and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.